Overview

A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
To obtain absorption, metabolism and excretion data for parent drug and any metabolites.
Phase:
Phase 1
Details
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.